Let's compare two companies that depend on science - IBM and GlaxoSmithKline.
Let's say IBM discovers a new method of lithography for building microchips. They publish their results, and their results are replicated. More importantly, IBM gets a new, presumably better way of making microchips.
GlaxoSmithKline makes a new drug that treats a psychological illness. To some degree, because there are no objective physical tests for most psychological illnesses, the determination of effectiveness is made subjectively.
Both companies want the science to turn out right, because it makes them money. One of them has a much easier time massaging the results of any studies.